Is Centene (CNC) Below Fair Value After Raised Earnings Guidance?

Centene has delivered a sharp share price climb over the past year, which puts a fresh spotlight on whether the current US$67.05 level is supported by its earnings power. With the business reshaping costs and its portfolio, the question for anyone looking at Centene today is how far those changes are already reflected in the valuation.

• The stock is up 79.6% over the past year, which raises the bar for what its earnings need to deliver to keep that move looking justified.
• Recent cost cuts, debt reduction and a focus on profitability in key lines like Marketplace and Medicare Advantage can influence how durable Centene's earnings base looks and how investors frame the multiple they are prepared to pay.
• The analysts covering Centene have run their own numbers. See what analysts think Centene's shares could be worth.

For investors, the debate is whether Centene's current price is appropriately aligned with what its earnings suggest the business is worth.

To see how Centene's sharp rerating compares with other companies focused on earnings power, line it up next to 26 high quality undervalued stocks.

Is Centene a Bargain on Earnings?

The P/E ratio fits Centene because profit is a key yardstick for managed care businesses that run on scaled contracts and tight underwriting. On this measure, Centene trades at about 22.7x earnings, which is below the broader healthcare sector on 25.4x and also under the peer group on roughly 28.6x.

The Fair Ratio framework, which looks at factors like earnings quality, margins, size and risk, points to a higher P/E than where Centene changes hands today. Because full year guidance has been raised after recent cost cuts and debt reduction, that gap suggests the market multiple has not fully closed the distance implied by those earnings expectations. Explore the numbers behind Centene's P/E valuation.

The Centene Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the Centene valuation puzzle leaves off by spelling out which earnings, growth and margin paths would need to play out for the stock to look meaningfully mispriced in either direction at today's US$67.05 level. They sit on the Community page for you to explore. Each one links its number to a specific view on how Centene's growth, profitability and risk profile could evolve, so you can come back and see how that thesis measures up as fresh information arrives.

One of the top community narratives on Centene: 21% undervalued

"The current valuation implies the share price does not yet fully reflect higher adjusted EPS guidance and balance sheet progress..."

Discover why this Narrative puts Centene at 21% undervalued.

One more crucial angle on Centene that this valuation has not touched

Price and current earnings only tell part of the story for Centene, because professional coverage also sketches where the business could be a few years from now, and that outside lens can sharpen how you think about today's number. Explore where analysts expect Centene to be in a few years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com